Universal DX Initiates Clinical Trial for FDA Approval of Signal-C® Colorectal Cancer Screening Blood Test
/
DateAug 15 2024
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Universal DX (“UDX”), a biotech company dedicated to transforming cancer into a curable disease by detecting it early, today announced closure of the... Read More →